Oskare Capital

Oskare Capital is a venture capital firm headquartered in Paris and London. It invests at venture stage in deeptech and life sciences, with a particular interest in the endocannabinoid system.

Products and services

• Venture investment: a fund covering start-ups from seed stage through to patient treatment.
• Therapeutics focus: companies developing cannabinoid and other molecules that target the endocannabinoid system.
• Ecosystem investments: services and products that support this growing market.
• ESG-compatible structure: the fund describes itself as compatible with alternative investment fund manager and ESG rules.

Who it serves

European teams with strong intellectual property and scalable technology. The fund states it will not invest in cannabis production or recreational cannabis. Its portfolio includes a synthetic biology dye maker, a botanical processing firm, a chronic pain digital clinic, a conference and data business, and a clinical-stage drug developer.

Key facts

• Based in: Paris and London
• Management team: located in Paris and London
• Fund: Oskare Fund I